How to buy DaVita HealthCare Partners stock (DVA)

DaVita HealthCare Partners is a medical care facilities business based in the US. DaVita HealthCare Partners shares (DVA) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $147.54 – a decrease of 3.4% over the previous week. DaVita HealthCare Partners employs 70,000 staff and has a trailing 12-month revenue of around $12.7 billion.

Our top picks for where to buy DaVita HealthCare Partners stock

Buy DaVita HealthCare Partners stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

DaVita HealthCare Partners stock price (NYSE: DVA)

Use our graph to track the performance of DVA stocks over time.

DaVita HealthCare Partners shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$147.54
52-week range	$103.40 - $169.52
50-day moving average more info button	$157.44
200-day moving average more info button	$146.30
Wall St. target price	$156.90
PE ratio more info button	15.8147
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$9.28

Is it a good time to buy DaVita HealthCare Partners stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

DaVita HealthCare Partners price performance over time

Historical closes compared with the close of $146.76 from 2024-12-18

1 week (2024-12-13)	-3.91%
1 month (2024-11-20)	-9.07%
3 months (2024-09-20)	-10.51%
6 months (2024-06-20)	4.65%

1 year (2023-12-20)	41.29%
2 years (2022-12-20)	107.23%
3 years (2021-12-20)	37.25%
5 years (2019-12-20)	99.13%

Is DaVita HealthCare Partners stock undervalued or overvalued?

Valuing DaVita HealthCare Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DaVita HealthCare Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

DaVita HealthCare Partners's P/E ratio

DaVita HealthCare Partners's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, DaVita HealthCare Partners shares trade at around 16x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

DaVita HealthCare Partners's PEG ratio

DaVita HealthCare Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1059. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DaVita HealthCare Partners's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

DaVita HealthCare Partners's EBITDA

DaVita HealthCare Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.7 billion.

The EBITDA is a measure of a DaVita HealthCare Partners's overall financial performance and is widely used to measure a its profitability.

DaVita HealthCare Partners financials

Revenue TTM	$12.7 billion
Operating margin TTM	16.28%
Gross profit TTM	$3.4 billion
Return on assets TTM	6.94%
Return on equity TTM	44.88%
Profit margin	6.53%
Book value	$4.68
Market Capitalization more info button	$12 billion

TTM: trailing 12 months

DaVita HealthCare Partners share dividends

We're not expecting DaVita HealthCare Partners to pay a dividend over the next 12 months.

Have DaVita HealthCare Partners's shares ever split?

DaVita HealthCare Partners's shares were split on a 2:1 basis on 8 September 2013 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your DaVita HealthCare Partners shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for DaVita HealthCare Partners shares which in turn could have impacted DaVita HealthCare Partners's share price.

DaVita HealthCare Partners share price volatility

Over the last 12 months, DaVita HealthCare Partners's shares have ranged in value from as little as $103.4 up to $169.515. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while DaVita HealthCare Partners's is 0.887. This would suggest that DaVita HealthCare Partners's shares are less volatile than average (for this exchange).

DaVita HealthCare Partners overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc.

Frequently asked questions

null
What percentage of DaVita HealthCare Partners is owned by insiders or institutions?
Currently 48.537% of DaVita HealthCare Partners shares are held by insiders and 50.245% by institutions. How many people work for DaVita HealthCare Partners?
Latest data suggests 70,000 work at DaVita HealthCare Partners. When does the fiscal year end for DaVita HealthCare Partners?
DaVita HealthCare Partners's fiscal year ends in December. Where is DaVita HealthCare Partners based?
DaVita HealthCare Partners's address is: 2000 16th Street, Denver, CO, United States, 80202 What is DaVita HealthCare Partners's ISIN number?
DaVita HealthCare Partners's international securities identification number is: US23918K1088 What is DaVita HealthCare Partners's CUSIP number?
DaVita HealthCare Partners's Committee on Uniform Securities Identification Procedures number is: 89151A107